Content Tagged Clive Wasserfall Subscribe to RSS Feed

Insulin Production. Florescent microscopic slide

Type 1 Diabetes Patients Retain Some Ability to Produce Insulin, UF Health Researchers Find

Published: Oct 13th, 2017

As an autoimmune disease, Type 1 diabetes has long been thought to result from a complete immune system killing of the insulin-producing beta cells within the pancreas. Now, University of […]

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes

Published: Nov 21st, 2015

UFDI and nPOD investigators found that the presence of β-cells as well as insulitis several years after T1D diagnosis in children and young adults suggest that the chronicity of islet […]

Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

Published: Oct 18th, 2015

UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]

Immunoproteomic Profiling of Anti-Viral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays

Published: Oct 12th, 2015

UFDI investigators and collaborators at Arizona State University found that the Epstein-Barr virus may have a role in type 1 diabetes development.

UFDI researchers work to develop type 1 diabetes vaccine

Published: Sep 15th, 2015

Two recent publications explored different methods of delivering a vaccine for type 1 diabetes, both of which prevented 40 percent of mice from developing the disease.

UF researchers release publication on the influence of type 1 diabetes on pancreatic weight

Published: Sep 13th, 2015

UFDI faculty and a University of Miami researcher found that “reduced pancreas weight allows for comparisons across a wide range of donor ages by eliminating confounding variables.”

UF researchers publish paper on myxoma virus and T lymphocytes

Published: Aug 26th, 2015

The publication found that myxoma virus binds human T lymphocytes but does not enter and infect T cells until after activation.

$1.5 million grant targets immune cell therapies in Type 1 diabetes

Published: Dec 23rd, 2014

Benjamin Keselowsky, Ph.D. has received a new NIH R01 grant for “Biomaterial Delivery System for Type 1 Diabetes Vaccine”. Funded by the National Institute of Diabetes and Digestive and Kidney Diseases in collaboration with UF Diabetes Institute Director, Mark Atkinson, Ph.D., and Clive Wasserfall, this, $1.5M grant will fund the investigation of biodegradable microparticle/hydrogel formulations delivering immuno-modulatory factors to targeted immune cell types for the prevention and reversal of T1D.

UF Researchers Present at ADA’s 74th Scientific Sessions

Published: Jun 21st, 2014

UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.

Combining efforts to beat Type 1 diabetes

Published: May 29th, 2014

Learn about the latest drug-delivery system developed by University of Florida researches that holds the promise for ways to treat and ultimately prevent persons from developing Type 1 Diabetes. The joint effort is bringing research closer to a cure.